LUGPA Policy Update - CMS Announces New Marketplace Anti-Fraud Actions

October 2026

At a Glance

What Happened:
CMS announced a series of actions to combat fraud and improper enrollment in the federal Health Insurance Marketplace. CMS has canceled approximately 315,000 unauthorized enrollments covering more than 760,000 individuals and estimates the action will return approximately $2.2 billion in taxpayer-funded subsidies. The agency is also increasing oversight of Marketplace agents and brokers and strengthening requirements for identity verification and consumer authorization.

Why It Matters:
The initiative primarily affects the Federal Marketplace rather than Medicare physician payment, so the direct impact on LUGPA members is limited. However, patients whose Marketplace coverage is canceled or changed could experience disruptions in eligibility or coverage, potentially creating additional verification and billing issues for practices.

CMS is also establishing a more coordinated anti-fraud effort within CMS and HHS and expanding enforcement against agents and brokers. More than 200 non-compliant agents and brokers have received termination notices since January, according to CMS.

Key Policy Signals:

• Increased CMS scrutiny of enrollment and eligibility activity.
• Greater identity and documentation requirements for Marketplace applications.
• Additional oversight and enforcement involving agents and brokers.
• Continued use of data and coordination with insurers to identify potentially improper activity.
• A broader emphasis on fraud, waste, abuse, and program integrity across federal health programs.

Potential Impact on LUGPA Members

Independent urology practices are unlikely to face significant new requirements as a direct result of this announcement. However, practices that treat Marketplace patients should be aware that ongoing enrollment reviews could result in changes to patients' coverage or eligibility information. Practices may also encounter additional questions from patients or insurers when coverage is canceled or modified.

The announcement is also worth monitoring as part of the broader CMS focus on program integrity and increased oversight of federal health programs. LUGPA will continue to track developments that could create additional administrative requirements or affect patient access and coverage.

LUGPA Takeaway

This is not a core LUGPA policy issue, but it is relevant as a broader indicator of CMS's increased focus on identifying improper activity, strengthening verification requirements, and recovering federal healthcare dollars. LUGPA will monitor the implementation of these changes for any downstream effects on independent practices and their patients.

Source: CMS: Federal Marketplace Anti-Fraud Actions